abstract |
Compounds of formula 1 or pharmaceutically acceptable salts thereof are provided: n nwhich are agonists or partial agonists of the 2C subtype of brain serotonin receptors. The compounds, and compositions containing the compounds, can be used to treat a variety of central nervous system disorders such as schizophrenia. |